How Much Does Peptide Therapy Cost in 2026? A Complete Price Guide by Peptide Type

Peptide therapy cost in 2026 ranges from $100 to $1,349 per month, depending on the peptide, your provider, and whether insurance applies. Most patients pay $150–$500/month for compounded protocols. Brand-name GLP-1s without insurance are the most expensive category. Tissue repair peptides are the most affordable.

This guide breaks down the real numbers — by peptide type, provider model, and what your insurance or HSA can actually cover.

What You're Actually Paying For: The Cost Framework

Peptide therapy is not a single product. It's a category spanning FDA-approved medications, compounded pharmaceutical preparations, and investigational compounds. Each sits in a different regulatory and pricing tier.

Five variables drive the final number you pay:

• FDA approval status — approved peptides have undergone Phase 3 trials; that cost is baked into the price
• Manufacturing standard — cGMP pharmaceutical grade vs. compounding pharmacy vs. research-grade
• Provider model — in-person specialist clinic vs. telehealth vs. direct-to-patient online programs
• Whether labs and consults are bundled — many programs charge these separately
• Geographic market and demand — high-demand areas and high-overhead clinics charge more

Understanding which category your peptide falls into is the first step to knowing what a fair price looks like.

How Much Does Peptide Therapy Cost in 2026? GLP-1 Peptides (Weight Loss & Metabolic)

GLP-1 receptor agonists — semaglutide, tirzepatide, liraglutide — are the most widely used and most expensive class of therapeutic peptides. They are also the category most likely to receive insurance coverage.

Brand-Name vs. Compounded: The Biggest Pricing Gap in Peptide Therapy

Brand-name semaglutide costs $935–$1,349 per month at retail, while compounded semaglutide runs $200–$500 per month. Brand-name tesamorelin (Egrifta) runs $800–$1,200 versus $200–$400 compounded.

Compounded formulations are prepared by licensed 503A or 503B pharmacies. Patients should verify that the pharmacy holds 503A or 503B registration and provides batch-specific certificates of analysis. Compounded peptides are not FDA-approved products — they are legally prepared copies under specific regulatory conditions.

What Telehealth Changes

Telehealth peptide clinics generally charge 20–40% less than brick-and-mortar practices because of lower overhead. Many now offer all-inclusive monthly plans ($250–$500) that bundle peptides, labs, and provider visits.

First-Month Setup Costs

The first month is typically more expensive because it includes initial labs and consultation. Budget an additional $200–$400 for baseline bloodwork and the initial clinical evaluation.

How Much Does Peptide Therapy Cost in 2026? Growth Hormone Peptides (Anti-Aging & Body Composition)

Growth hormone secretagogues — CJC-1295, ipamorelin, sermorelin, tesamorelin — are among the most prescribed protocols in wellness and anti-aging clinics.

CJC-1295 / Ipamorelin

CJC-1295 and ipamorelin, often stacked together, are among the most prescribed peptide protocols in wellness clinics. Compounding pharmacy pricing typically runs $200–$400 per month for the stack at standard dosing. Clinic consultation and monitoring fees are usually separate, often $200–$500 for initial evaluation and $100–$300 for periodic follow-up. Lab work for IGF-1 monitoring runs $50–$150 per draw depending on lab and insurance.

The 2023 FDA review of 503A compoundable peptides moved CJC-1295 and ipamorelin into more restricted status, narrowing access. Patients should expect availability to be variable across pharmacies. However, the regulatory picture shifted in early 2026.

On February 27, 2026, HHS Secretary Kennedy announced that approximately 14 of the 19 peptides previously classified as Category 2 restricted — including BPC-157, TB-500, CJC-1295, ipamorelin, and sermorelin — are expected to return to Category 1 status, meaning they can again be legally compounded by 503A and 503B pharmacies. That reclassification is expected to expand supply and stabilize pricing through 2026.

Sermorelin

Sermorelin is generally the most affordable growth hormone secretagogue. These typically run $150–$350/month and are commonly prescribed by anti-aging and hormone optimization clinics.

Tesamorelin

Tesamorelin (brand Egrifta) is FDA-approved for HIV-associated lipodystrophy, with a list price of $3,000–$4,000+ per month. Compounded tesamorelin runs $200–$400 per month.

How Much Does Peptide Therapy Cost in 2026? Tissue Repair Peptides (BPC-157, TB-500)

Tissue repair peptides are the most affordable category in clinical peptide therapy. They are also the most commonly used for short, defined protocols — which keeps total costs lower than ongoing metabolic programs.

BPC-157

BPC-157 (Body Protection Compound-157) does not have FDA-approved commercial products, so all available formulations are either compounded or research-grade. Compounded BPC-157 from licensed 503A or 503B pharmacies typically costs $100–$300 per month, depending on dosage, route of administration (injectable vs. oral capsules), and provider markup.

Research-grade BPC-157 from online vendors runs $20–$60 per 5 mg vial. A typical month of use at 250–500 mcg daily uses one to two vials, putting monthly cost at $20–$120 for research-grade material. These products are labeled not for human use and carry no quality assurance.

This is a critical distinction. Research-grade peptides are not verified for sterility, purity, or accurate dosing. The apparent cost savings come with real clinical risk.

TB-500 (Thymosin Beta-4)

TB-500 research-grade pricing runs $40–$100 per 5 mg vial. A typical month at 2–5 mg per week uses about two vials, putting monthly cost at $80–$200 for research-grade material. Clinical compounded programs run $150–$300/month.

The BPC-157 + TB-500 Stack

These two are frequently combined for musculoskeletal injury recovery and gut repair. An advanced anti-aging and repair stack (GHK-Cu + BPC-157 + TB-500 + epithalon + MOTS-c) runs $300–$600 per month. A simpler BPC-157 + TB-500 protocol through a licensed clinic typically costs $300–$500/month bundled.

Longevity & Cognitive Peptides: What Do They Cost?

Longevity-focused protocols — GHK-Cu, epithalon, MOTS-c, selank, semax — are primarily used in anti-aging and optimization medicine. Most are research-grade or obtained through specialty compounding clinics.

Typical monthly longevity stack budgets: a basic stack (GHK-Cu + BPC-157) runs $80–$160; an intermediate stack (GHK-Cu + BPC-157 + epithalon cycled) runs $100–$200; an advanced stack (GHK-Cu + BPC-157 + TB-500 + epithalon + MOTS-c) runs $300–$600 per month. Most protocols cycle peptides — 6–12 weeks on, 4–8 weeks off — which reduces true annual cost but not the per-month-on-cycle cost.

Cognitive peptides such as selank and semax are primarily available through research-grade suppliers.

Hidden Costs Most Patients Miss

The peptide itself is rarely your only expense. These add-ons are real and routinely overlooked:

Initial labs: Baseline bloodwork before starting any protocol runs $150–$400 depending on the panel. IGF-1, fasting insulin, metabolic panel, and thyroid markers are standard for most protocols. Meto's lab panels can help streamline this step before your first clinical appointment.

Follow-up visits: Most peptide protocols include follow-up visits at 4–8 weeks and then quarterly. Each follow-up typically costs $75–$200. Over a year, this adds $300–$800 to total cost, but is essential for safety monitoring and dose optimization.

Injection supplies: Syringes, alcohol swabs, sharps containers, and bacteriostatic water add $15–$40/month.

Shipping: Telehealth programs typically ship medications directly. Some charge $15–$30/month for cold-chain shipping.

Reconstitution supplies: Lyophilized (freeze-dried) peptides require bacteriostatic water. Your pharmacy should supply this, but confirm upfront.

Does Insurance Cover Peptide Therapy in 2026?

The coverage landscape splits sharply across peptide categories.

What Insurance Will and Won't Cover

FDA-approved peptides with insurance coverage include semaglutide (for diabetes/obesity), tirzepatide (for diabetes/obesity), tesamorelin (for HIV lipodystrophy), and bremelanotide (for HSDD). Compounded peptides — BPC-157, TB-500, sermorelin, CJC-1295, ipamorelin — receive zero insurance coverage and are 100% self-pay.

Private insurance coverage varies significantly by carrier and plan. Approximately 85–90% of commercial plans cover at least one GLP-1 agonist. Growth hormone peptides such as tesamorelin are covered only for FDA-approved indications with extensive documentation. Research peptides such as BPC-157 and TB-500 are never covered.

The Medicare Exception

Medicare is prohibited by law from covering drugs prescribed solely for weight loss or obesity, even if FDA-approved for that indication. This is why Wegovy (semaglutide for weight loss) is not covered despite Ozempic (same drug for diabetes) being covered.

Prior Authorization: What to Expect

For GLP-1s prescribed for weight management, prior authorization is common. Your provider will need to document medical necessity — BMI, comorbidities, and prior treatment history. Meto's Prescription Weight Loss Program includes clinical support for this process.

How Much Does Peptide Therapy Cost in 2026? Using HSA and FSA to Reduce Your Bill

Tax-advantaged health accounts are one of the most underused tools for managing peptide therapy costs. If you're paying out of pocket, this matters.

What Qualifies

Health Savings Accounts (HSA) and Flexible Spending Accounts (FSA) can be used for prescribed peptides even if insurance doesn't cover them, as long as they are legally prescribed by a licensed provider for a medical condition.

Both semaglutide and tirzepatide can be HSA and FSA eligible in 2026. The IRS does not pay attention to what medication you used — it pays attention to why a licensed provider prescribed it. Get that documentation right, and you can pay for your GLP-1 program with pre-tax dollars.

The Real Tax Math

At $250/month for compounded GLP-1s, you spend $3,000 annually. Using pre-tax HSA or FSA funds effectively saves 20–35% on that total, depending on your tax bracket.

For 2026, the FSA contribution limit is $3,400 (approximately $283/month). For HSAs in 2026, you can contribute up to $4,400 for individual coverage or $8,750 for family plans.

What You Need to Make It Work

1. Obtain a prescription from a licensed provider
2. Request a Letter of Medical Necessity documenting your diagnosis and the clinical rationale
3. Pay using your HSA/FSA debit card or submit itemized receipts for reimbursement
4. Keep all documentation — prescription, diagnosis code, and receipts — in your records

The most common reason HSA/FSA claims are denied is missing documentation of medical necessity — not the medication itself.

Provider Type vs. Price: Where You Get Your Peptides Matters

Most peptide therapy costs aren't covered by traditional insurance, though Medicare may cover certain FDA-approved options like semaglutide for diabetes management.

The Meto platform connects patients with metabolic specialists who can evaluate whether peptide therapy fits within a structured, insurance-reviewed care plan — not just a standalone prescription.

What Should You Actually Budget? Monthly Cost Summary by Goal

The average monthly cost for a peptide therapy program in 2026 is roughly $200–$400/month once past the initial setup phase. GLP-1 programs run higher; tissue repair peptide protocols run lower.

5 Ways to Reduce Your Peptide Therapy Cost Without Cutting Corners

1. Use HSA/FSA funds. Pre-tax dollars reduce your effective cost by 20–35%. Any prescribed peptide for a documented medical condition qualifies.
2. Choose telehealth over in-person for routine follow-ups. Telehealth peptide clinics generally charge 20–40% less than brick-and-mortar practices.
3. Apply for manufacturer patient assistance programs. For brand-name GLP-1s, programs from Novo Nordisk and Eli Lilly can reduce costs to as little as $25/month for qualifying patients.
4. Request bundled pricing. Many clinics offer lower per-month rates when labs, consults, and medication are bundled. Ask specifically before agreeing to à la carte billing.
5. Get insurance documentation right. A well-documented Letter of Medical Necessity, with the correct ICD-10 diagnostic codes, is often the difference between approval and denial for GLP-1 coverage.

The Difference Between Price and Cost

A $40 vial of research-grade BPC-157 is not the same product as $200/month of clinic-compounded BPC-157. The price variation in peptide therapy is not random. It reflects fundamental differences in manufacturing standards, regulatory oversight, distribution channels, and clinical support.

Research peptides that cost 70% less than pharmacy compounds may be contaminated, underdosed, or degraded. Medical complications from low-quality peptides cost far more than the savings.

When you're evaluating peptide therapy options, always distinguish between what you're paying and what it's actually costing you — in safety, clinical support, and long-term outcomes.

Conclusion

Peptide therapy cost in 2026 is not a single number. It's a range shaped by your clinical goals, the specific peptides used, your provider model, and whether insurance or HSA funds apply.

Most patients working through a licensed provider pay $200–$500/month. GLP-1 programs sit at the higher end of that range and offer the strongest insurance coverage opportunities. Tissue repair protocols are shorter and more affordable. Growth hormone peptides sit in the middle, with costs shifting significantly depending on whether they're bundled with clinical oversight.

The most important decision isn't which peptide to start with — it's starting with a provider who can evaluate your metabolic picture, document your case properly for insurance, and build a plan that's matched to your biology.

That's exactly what Meto does. Get a transparent, insurance-reviewed peptide care plan at Meto.

Frequently Asked Questions

How much does peptide therapy cost per month on average in 2026?

Most patients pay $200–$500 per month once past the initial setup phase. GLP-1 programs such as compounded semaglutide typically run $250–$500/month. Tissue repair protocols using BPC-157 or TB-500 run $100–$300/month. Growth hormone secretagogue protocols such as CJC-1295/ipamorelin typically cost $200–$400/month from a compounding pharmacy, plus labs and consult fees.

Does insurance cover peptide therapy in 2026?

Insurance covers FDA-approved peptides prescribed for their approved indications. Semaglutide (Ozempic) for type 2 diabetes is covered by most commercial plans. Wegovy (semaglutide for obesity) coverage varies by plan. Compounded peptides — BPC-157, TB-500, CJC-1295, and most growth hormone peptides — are never covered by insurance and are 100% self-pay. Prior authorization is common for GLP-1s used in weight management.

Can I use my HSA or FSA to pay for peptide therapy?

Yes, in most cases. HSA and FSA funds can cover any peptide therapy that is legally prescribed by a licensed provider for a documented medical condition. The key requirement is a Letter of Medical Necessity from your provider. For 2026, HSA contribution limits are $4,400 for individuals and $8,750 for families. Using pre-tax dollars reduces your effective cost by 20–35% depending on your tax bracket.

Is compounded semaglutide safe and legal in 2026?

Compounded semaglutide is legal when prepared by an FDA-registered 503A or 503B pharmacy and dispensed with a valid prescription from a licensed provider. It is not an FDA-approved product, but it is a regulated pharmaceutical preparation. Compounded semaglutide has been subject to evolving FDA shortage determinations — availability and legal status can change. Always verify your pharmacy's registration status and request a certificate of analysis for your medication.

What is the cheapest legitimate route for peptide therapy?

For GLP-1 peptides, compounded semaglutide through a telehealth program starts as low as $150–$200/month and represents the lowest legitimate entry point. For tissue repair peptides, compounded BPC-157 from a licensed clinic runs $100–$200/month. Research-grade peptides from online vendors are cheaper but are not verified for human use — they carry quality and safety risks that make them a false economy for clinical purposes.

Why is there such a large price gap between brand-name and compounded peptides?

Brand-name FDA-approved peptides carry the cost of Phase 3 clinical trials, cGMP manufacturing, regulatory approval, and branded distribution infrastructure. Compounding pharmacies skip those costs because they produce the molecule directly for individual patient prescriptions without the trial and approval burden. The price gap — sometimes 5–8x for semaglutide — reflects this regulatory pathway difference, not necessarily a quality difference in the peptide molecule itself.